Literature DB >> 7150474

Ability of CEA blood levels to reflect tumour burden: a study in a human xenograft model.

J B Quayle.   

Abstract

The relationship of serum carcinoembryonic antigen (CEA) levels to tumour size and antigen content was studied in artificially immune-deprived mice bearing human colonic, breast and lung tumour xenografts. Size was measured as in vivo volume and tumour weight at post-mortem. A multiple implant technique combined with early harvest was used to minimize centrilobular tumour necrosis. CEA was extracted from resected tumours with perchloric acid. A radioimmunoassay using chemical precipitation was used to estimate CEA in blood samples. A correlation was found between CEA blood levels and tumour size in half the tumour lines, in contrast to a recent report (Lewis & Keep, 1981). The CEA content was found to be constant for one tumour line but not another. The possibility that central necrosis in xenograft tumours may account for the discrepancies is discussed. There may be serious limitations for the use of xenograft tumour models for studying the biology of CEA.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7150474      PMCID: PMC2011084          DOI: 10.1038/bjc.1982.187

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  29 in total

1.  A human gastric choriocarcinoma cell line with human chorionic gonadotropin and placental alkaline phosphatase production.

Authors:  T Kameya; H Kuramoto; K Suzuki; T Kenjo; T Oshikiri; H Hayashi; M Itakura
Journal:  Cancer Res       Date:  1975-08       Impact factor: 12.701

2.  Carcinoembryonic antigen in patients with gynecologic malignancies.

Authors:  P J DiSaia; B J Haverback; B J Dyce; C P Morrow
Journal:  Am J Obstet Gynecol       Date:  1975-01-15       Impact factor: 8.661

3.  OCULAR SYMPTOMS IN GLANDULAR FEVER.

Authors:  B R Jones
Journal:  Br J Ophthalmol       Date:  1957-03       Impact factor: 4.638

4.  Serum CEA levels in a human colonic adenocarcinoma (LOVO) xenograft system.

Authors:  J J Stragand; L Y Yang; B Drewinko
Journal:  Cancer Lett       Date:  1980-07       Impact factor: 8.679

5.  Carcinoembryonic antigen in 228 patients with carcinoma of the lung.

Authors:  R G Vincent; T M Chu; T B Fergen; M Ostrander
Journal:  Cancer       Date:  1975-12       Impact factor: 6.860

6.  Carcinoembryonic antigen for monitoring patients with small cell carcinoma of the lung during treatment.

Authors:  T P Waalkes; M D Abeloff; K B Woo; D S Ettinger; R W Ruddon; P Aldenderfer
Journal:  Cancer Res       Date:  1980-12       Impact factor: 12.701

7.  The interpretation of marker protein assays: a critical appraisal in clinical studies and a xenograft model.

Authors:  D Raghavan; J Gibbs; R Nogueira Costa; J Kohn; A H Orr; A Barrett; M J Peckham
Journal:  Br J Cancer Suppl       Date:  1980-04

8.  Carcinoembryonic antigen (CEA) in patients with breast cancer.

Authors:  N M Borthwick; D W Wilson; P A Bell
Journal:  Eur J Cancer       Date:  1977-02       Impact factor: 9.162

9.  Variation in response of xenografts of colo-rectal carcinoma to chemotherapy.

Authors:  K Nowak; M J Peckham; G G Steel
Journal:  Br J Cancer       Date:  1978-04       Impact factor: 7.640

10.  Tumour lysis as a factor affecting blood levels of CEA.

Authors:  J B Quayle
Journal:  Br J Cancer       Date:  1982-08       Impact factor: 7.640

View more
  4 in total

Review 1.  Predictive tests in cancer chemotherapy. A reappraisal.

Authors:  R Osieka; S Seeber; C G Schmidt
Journal:  Klin Wochenschr       Date:  1984-03-01

2.  [The doubling time of circulating CEA as an individual prognostic criterion of recurrence in patients with gastrointestinal cancers].

Authors:  T Brümmendorf; F A Anderer; H J Staab; A Hornung; G Kieninger
Journal:  Klin Wochenschr       Date:  1986-01-15

3.  Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients.

Authors:  A Nicolini; C Colombini; L Luciani; A Carpi; L Giuliani
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

4.  Tumour lysis as a factor affecting blood levels of CEA.

Authors:  J B Quayle
Journal:  Br J Cancer       Date:  1982-08       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.